Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) EBT (2016 - 2025)

Cavitation Technologies' EBT history spans 16 years, with the latest figure at -$476000.0 for Q4 2025.

  • For Q4 2025, EBT fell 58.14% year-over-year to -$476000.0; the TTM value through Dec 2025 reached -$1.2 million, down 773.6%, while the annual FY2025 figure was -$993000.0, 326.2% down from the prior year.
  • EBT for Q4 2025 was -$476000.0 at Cavitation Technologies, down from -$258000.0 in the prior quarter.
  • Across five years, EBT topped out at $375000.0 in Q2 2024 and bottomed at -$483000.0 in Q2 2021.
  • The 5-year median for EBT is -$236500.0 (2023), against an average of -$156000.0.
  • The largest YoY upside for EBT was 239.08% in 2024 against a maximum downside of 1781.25% in 2024.
  • A 5-year view of EBT shows it stood at -$439000.0 in 2021, then skyrocketed by 34.62% to -$287000.0 in 2022, then surged by 94.43% to -$16000.0 in 2023, then plummeted by 1781.25% to -$301000.0 in 2024, then crashed by 58.14% to -$476000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVAT's EBT are -$476000.0 (Q4 2025), -$258000.0 (Q3 2025), and -$235000.0 (Q2 2025).